N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer

Journal Title: International Journal of Immunotherapy and Cancer Research - Year 2015, Vol 1, Issue 1

Abstract

Glutamate (Glu) mainly acts as an excitatory neurotransmitter in the central nervous system controlling variety of neuro-physiological functions like synaptic signaling, learning, memory, etc. However, uncontrolled or excessive production of glutamate is neurotoxic and can damage neurons by over activation of glutamate receptors termed as “glutamate excitotoxicity”. Apart from excitatory neurotransmitter role of glutamate, some recent observations suggest glutamate as a potential growth factor for tumor development. Till date suitable therapy for cancer is lagging behind due to several side effects. In the present review article, a link between ionotropic glutamate receptor i.e. N-methyl-D-aspartate (NMDA) receptors (NMDARs) and cancer has been mainly focused. Regulation of cancer cells by NMDARs is an emerging or evolving concept. Besides neurons, NMDAR subunits are expressed in various types of cancer cells. Based upon existing literature, we suggest that NMDARs could serve as a therapeutic target against various types of cancer.

Authors and Affiliations

Mehrotra Aditi, Koiri Raj Kumar

Keywords

Related Articles

A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers

We find more and more often patients with two or more synchronous or metachronous cancers, who raise various issues on the risk factors and pathways. A polycythemia vera male patient, diagnosed at 44 years, evolved towar...

Probiotics and Bone Health: It takes GUTS to Improve Bone Density

Probiotics are a class of symbiotic bacteria whose administration in adequate amount provides health benefits to the host by altering the composition of gut microbiota. The gut microbiota is known to regulate both the ho...

Titanium Mesh Reconstruction after Solitary Sternal Plasmacytoma Surgery-A Case report

We present chest wall reconstruction with titanium mesh in a patient who underwent sternal resection due to solitary plasmacytoma (SP). A 35 year old female was admitted to The Thoracic Surgery Department of University C...

SMART Drug Based Targeted Delivery: A New Paradigm for Nanomedicine Strategies

Introduction: Targeted drug delivery systems are nanoscale drug carrier molecules designed for improving the communication of cellular and molecular components and biodistribution of tumour targeted drug (chemo) therapeu...

Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis

The 5-year cumulative incidence rate of hepatocellular carcinoma (HCC) in chronic HBV -infected liver cirrhosis (LC) patients was up to 5%-30%. However, existing medical interventions can’t cure chronic HBV -infected LC...

Download PDF file
  • EP ID EP348702
  • DOI 10.17352/2455-8591.000004
  • Views 90
  • Downloads 0

How To Cite

Mehrotra Aditi, Koiri Raj Kumar (2015). N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer. International Journal of Immunotherapy and Cancer Research, 1(1), 13-17. https://europub.co.uk/articles/-A-348702